Breast Cancer, Adjuvant Medications
Drugs (by generic name) associated with Breast Cancer, Adjuvant
The following drugs and medications are in some way related to, or used in the treatment of Breast Cancer, Adjuvant. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
| Drug Name |
Reviews | Ratings |
||
|---|---|---|---|---|
| trastuzumab systemic (Pro, More...) | 0 review(s) | Rate It! | 9.0 | |
| tamoxifen systemic (Pro, More...) | 0 review(s) | Rate It! | 7.0 | |
| paclitaxel systemic (Pro, More...) | 0 review(s) | Not rated - Be the first | ||
| letrozole systemic (Pro, More...) | 0 review(s) | Not rated - Be the first | ||
| epirubicin systemic (Pro, More...) | 0 review(s) | Not rated - Be the first | ||
Breast Cancer, Adjuvant Medications in the Pipeline
- May 11, 2005 - Further Trial Data Awaited for Bonefos in the U.S.
- January 7, 2005 - Berlex Receives Approvable Letter for Bonefos (Clodronate) for Adjuvant Treatment of Breast Cancer
- September 9, 2004 - Bonefos Accepted for Filing and Granted Priority Review by FDA
Latest Breast Cancer, Adjuvant Blog Post
Gene Alteration May Affect Breast Cancer Therapy
TUESDAY, April 28 -- Certain gene alterations improve breast cancer patients' response to anthracycline therapy, Canadian researchers say.
They found that women with tumors that carried topoisomerase II alpha (TOP2A) gene alterations had 65 percent better...
View all Breast Cancer, Adjuvant blog posts.
Breast Cancer, Adjuvant Support Group Questions
Ask a Question about Breast Cancer, Adjuvant:
Learn more about Breast Cancer, Adjuvant
Medical encyclopedia results for:
